Other functions TAS:: 750849 reformulation of cancer therapeutics using nanotechnology

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201200092C
Awardee
Awarding agency
Obligated
$191,326

Award facts

Contract value 100% obligated
$191,326.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Worth, TX 76133, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 3 $0
Change Order 2 $0
Other Administrative Action 1 $0
Original award $191,326

About this award

This is a $191,326 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lipomedics LTD, a small business limited liability company, to reformulate cancer therapeutics using nanotechnology. The contract has a ceiling value of $191,326 and an ultimate completion date of November 1, 2013. This contract is set aside for total small business participation.

Quick answers

Who was awarded contract HHSN261201200092C?

HHSN261201200092C was awarded to Lipomedics LTD by National Cancer Institute (National Institutes of Health) on September 20, 2012.

How much is contract HHSN261201200092C worth?

The government has obligated $191,326 on HHSN261201200092C.

Was contract HHSN261201200092C competed?

The extent of competition for HHSN261201200092C was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award